We invite you to benefit from our more than 20 years’ experience in market access & health economic outcomes research in order to bring your product ahead.
About Us
The Agency for Health Economic Assessment and Dissemination – AHEAD - is a specialized consulting agency that supports clients in the planning, generation and dissemination of health economic evidence as well as in obtaining market access and reimbursement in Germany.
The AHEAD philosophy is to provide high-quality, product-specific and client-need-specific consulting & research activities that will be delivered on time.
Contact
General Manager
AHEAD GmbH
Wilhelm-Leibl-Str. 7
D-74321 Bietigheim-Bissingen, Germany
Phone + 49 (0) 7142 914 1470
Mobile + 49 (0) 1577 194 8125
E-Mail Bjoern.Schwander@ahead-net.de
Please download and save the AHEAD - Capability Presentation.and the AHEAD Presentation of Health Economic Showcases.
Our professional indemnity and general liability are secured by the exali insurance for consulting companies.
News
We're announce the publication of a new paper titled "Holistic Modelling as a Catalyst for Effective Obesity Policy" authored by Joanna McLaughlin, Carlos Sillero Rejon, Mike Bell, Bjoern Schwander, Karen Coulman, and Hugh McLeod. This important work, published in BMJ, emphasizes the need for multifaceted interventions and system-wide modelling to transition from piecemeal policy-making to an equitable and cost-effective obesity strategy. You can read the full article here. Congratulations to all the authors for their valuable contribution to this crucial field of study!
Thank you for joining us for the ISPOR MD&D Webinar on "The Role of RWE for Medical Device and Diagnostic Market Access in Europe." We are grateful to our esteemed speakers—Axel Mühlbacher, Stephen J. Duffield, Sandrine Bourguignon, and James Lavin—who provided invaluable insights from their respective German, UK, and French perspectives, as well as from the industry viewpoint. Your participation made this event a success. If you missed it or wish to revisit the discussions, you can watch the webinar recording here.
Great thanks to Katharina Klesper (geb. Kolbe), Siegbert Rossol, Ken Herrmann and York Zöllner for their valuable contribution on the paper named "Cost-Effectiveness and Budget Impact Analyses of Selective Internal Radiation Therapy versus Atezolizumab Plus Bevacizumab from a German Statutory Health Insurance Perspective", which has just been published in ClinicoEconomics and Outcomes Research!